Prominent radiology society announces launch of new journal

America’s oldest radiology society announced June 13 that it will soon launch a new radiology journal. 

The American Roentgen Ray Society will begin publishing the Roentgen Ray Review, or R3, in early 2025. It will be published in addition to the society’s longstanding American Journal of Roentgenology, which has been active since 1907. 

The new journal will include "pictorial essays, case reports and expert commentary for today’s practicing radiologists,” an announcement said. 

ARRS is bringing John R. Leyendecker, MD, a current adjunct professor of radiology at University of Texas Southwestern in Dallas, on board as editor in chief of R3.

Leyendecker has been a faculty member of UT Southwestern since 2015. Prior to his current role there, he served as vice chair of clinical operations and vice chair of academic affairs. He completed his radiology residency at Emory University before completing his interventional radiology fellowship at Wilford Hall United States Air Force Medical Center, and his body MRI fellowship at the Mallinckrodt Institute in St. Louis, Missouri.  

“As the inaugural editor in chief of the Roentgen Ray Review, I see a unique opportunity to take the lead in providing image-rich, clinically relevant educational content for our busy members that is easy to read and apply,” he said in a statement. “I want to be responsive to the educational and practice needs of our members while being respectful of their time. My vision is to create a journal packed with practical information and tips that can be easily digested and immediately applied in a typical radiology practice.” 

His background in publishing makes him well-suited for the role. Leyendecker has published two textbooks, authored numerous research papers and clinical review articles, in addition to co-authoring multiple award-winning scientific abstracts. He has also served as a reviewer in multiple capacities for ARRS. 

Learn more about becoming a reviewer for R3 here

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup